Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jeremiah Faith
Icahn School of Medicine at Mount Sinai, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Vedanta Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Jeremiah Faith (the Principal Investigator in this study) receives financial compensation as a consultant and advisory board member for Vedanta Biosciences (a privately held manufacturer of IBD therapies). Dr. Faith also receives equity for his role with Vedanta. In addition, Dr. Faith receives financial compensation as a consultant for Janssen (manufacturers of IBD Therapies).
The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease
PROJECT NARRATIVE The nature of Inflammatory Bowel Disease (IBD) suggests genetically susceptible individuals are persistently colonized with mildly pathogenic microbial strains or communities that drive the chronic progressive intestinal disease. The majority of human gut microbiota strains remain stably colonized in our gastrointestinal tract from years to decades. Using microbial strain tracking methods, gnotobiotic mouse models of colitis, and human fecal and serum samples, we will test the hypothesis that proinflammatory microbes in the gastrointestinal tract of individuals with IBD will be preferentially found amongst the stable members of their gut microbiota.
Filed on May 17, 2019.
Tell us what you know about Jeremiah Faith's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Jeremiah Faith filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jeremiah Faith | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Vedanta Biosciences | $20,000 - $39,999 |
| Jeremiah Faith | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Vedanta Biosciences | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.